相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Predictive Value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPO-IIA, TOPOIIB and C-MYC Genes in Patients with Small Cell Lung Cancer (SCLC) Who Received First Line Therapy with Cisplatin and Etoposide
Niki Karachaliou et al.
PLOS ONE (2013)
The association of annexin A2 and cancers
Xiaohui Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
Michael S. Goldberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
An overview of esophageal squamous cell carcinoma proteomics
Yi-Jun Qi et al.
JOURNAL OF PROTEOMICS (2012)
A study of PKM2, PFK-1, and ANT1 expressions in cervical biopsy tissues in China
Yang Yuan et al.
MEDICAL ONCOLOGY (2012)
Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer
Jae Yun Lim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
Yaping Xu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Sybille Mazurek
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model
Wenhao Guo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang
Zan Liu et al.
MOLECULAR BIOLOGY REPORTS (2011)
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
Hua-shan Shi et al.
CANCER SCIENCE (2010)
Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors
ShuTao Zheng et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
MASS SPECTROMETRY-BASED CLINICAL PROTEOMICS: HEAD-AND-NECK CANCER BIOMARKERS AND DRUG-TARGETS DISCOVERY
Ajay Matta et al.
MASS SPECTROMETRY REVIEWS (2010)
Upregulation of plasma C9 protein in gastric cancer patients
Poh-Kuan Chong et al.
PROTEOMICS (2010)
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
Matthew G. Vander Heiden et al.
SCIENCE (2010)
Molecular Markers for Early Detection
Barbara K. Dunn et al.
SEMINARS IN ONCOLOGY (2010)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Esophageal cancer: epidemiology, pathogenesis and prevention
Sarah B. Umar et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
Epidemiology of oesophagogastric cancer
R. Lambert et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2007)
Tumor M2 pyruvate kinase in plasma of patients with urological tumors
J Roigas et al.
TUMOR BIOLOGY (2001)
分享论文
